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AUTOMATIZATION OF SERUM THYROXINE DETERMINATION 
A N D OF Ts-UPTAKE TEST* 
/. Habermann, J. Henner, K. Horn, I. zur Horst and P. C. Scriba 
Problem: 
Simple, rapid and inexpensive techniques were developed, since in this labora-
tory the requests for determinations of T4 an of T3-uptake exceed the number 
of 200 per week. This study was aimed at the development and the automatization 
of a competitive protein binding method for T4 on the basis of the automatic 
T3-uptake test in use. 
Methods: 
1. Ts-uptake-test: 0.2 ml serum and 0.4 ml T 3 - 1 2 5 J (0.1 ^Ci) in 0.5% albu-
min, 0.05 M sodium phosphate buffer p H 7.4 were equilibrated for 15 min at 
room temperature. 25 samples were simultaneously aspirated by a 25-channel 
peristaltic pump and delivered to 25 microcolumns containing 1 g sephadex G-25 
fine, placed in a thermoblock (29° C) for separation of protein-bound and so-
called free = dextran gel adsorbed T 3 - 1 2 5 J . The latter was totally eluted by 
pooled serum. With this procedure the same columns could be used for weeks. 
The whole separation was performed automatically within 25 min with a time-
controlled apparatus. 
2. Serum-Ti: 0.1 ml serum and 0.3 ml T 4 - 1 2 5 J (0.1 ^Ci) in 0.5% albumin, 
0.05 M sodium phosphate buffer ph 7.4 are incubated for 15 min at room 
temperature. The incubation mixtures are delivered as above to 1 g sephadex G-25 
s. f. columns, which are alkalized with 0.02 N NaOH, resulting in complete 
retention of cold endogenous and radioactive T4. The columns are then washed 
with 0.05 M sodium barbital buffer p H 8.6. Addition of 1.6 ml pregnancy serum 
(11:00 diluted in barbital buffer) caused competitive protein binding for T4 on 
the column and simultaneously eluted so bound T4. The relative radioactivity in 
this eluate indicated the amount of endogenous T4. The remaining hormones were 
finally totally eluted from the columns with excess serum, so that re-use of the 
columns was possible. For this CPB-method for serum T4, the same automatic 
apparatus as for the T3-uptake test is used. 
Results: 
The normal range of Ts-uptake (x ± 2 s) is 32—42%; quality control is 
satisfactory with a variation coefficient of 3.5% for a control serum checked for 
more than 2 years. Clinical data and quality control of the automatic CPB-
method for T4 wi l l be presented. 
* Supported by the Deutsche Forschungsgemeinschaft (SFB 51). 
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